Back to BNP Paribas Asset Management Holding S.A. BNP Paribas Asset Management Holding S.A.

CRNXCRNX
16 quarters

Position history for BNP Paribas Asset Management Holding S.A.BNP Paribas Asset Management Holding S.A.'s holdings in CRINETICS PHARMACEUTICALS IN

BNP Paribas Asset Management Holding S.A. holds 1.7M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $62.8M as of 2026-Q2. The position was decreased (-2.2% shares). CRNX represents 0.1% of BNP Paribas Asset Management Holding S.A.'s portfolio.

Current Value

$62.8M

Current Shares

1.7M

Total Value Change

+$53.9M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-2.2%
$62.8M0.1%$37.42
0
2026-Q1
Increased
1.7M
+29.3%
$62.3M0.1%$36.32
37
2025-Q4
Increased
1.3M
+59.1%
$61.8M0.1%$46.55
42
2025-Q3
Increased
834,031
+17.0%
$34.7M0.1%$41.65
34
2025-Q2
Increased
712,719
+16.7%
$20.5M0.1%$28.76
33
2025-Q1
Increased
610,839
+6.0%
$20.5M0.1%$33.54
30
2024-Q4
Increased
576,068
+17.2%
$29.5M0.1%$51.13
34
2024-Q3
Decreased
491,381
-10.0%
$25.1M0.1%$51.10
0
2024-Q2
Increased
546,234
+0.7%
$24.5M0.1%$44.79
29
2024-Q1
Decreased
542,708
-17.6%
$25.4M0.1%$46.81
0
2023-Q4
Increased
658,289
+3.9%
$23.4M0.1%$35.58
30
2023-Q3
Decreased
633,364
-1.2%
$18.8M0.1%$29.74
0
2023-Q2
Decreased
641,345
-7.2%
$11.6M0.0%$18.02
0
2023-Q1
Increased
691,201
+13.2%
$11.1M0.0%$16.06
31
2022-Q4
Increased
610,690
+34.1%
$11.2M0.0%$18.30
36
2022-Q3
New
455,419
-
$8.9M0.0%$19.64
38

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used